| BPL-003 Efficacy and Safety in Treatment Resistant Depression (NCT05870540) | Beckley Psytech Limited | 2023-09-14 |
| A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer (NCT05712174) | AHS Cancer Control Alberta | 2023-09-14 |
| Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT (NCT05917405) | Nantes University Hospital | 2023-09-14 |
| Parenting in 2 Worlds Multisite Trial (NCT06324318) | Arizona State University | 2023-09-14 |
| A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors (NCT06016062) | RemeGen Co., Ltd. | 2023-09-14 |
| Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia (NCT06085638) | M.D. Anderson Cancer Center | 2023-09-14 |
| Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes (NCT05832086) | Stephen Freedland | 2023-09-13 |
| A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma (NCT05797805) | Iterion Therapeutics | 2023-09-13 |
| A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease (NCT05878717) | GlaxoSmithKline | 2023-09-13 |
| Cryoablation Combined with Tislelizumab Plus Lenvatinib in Previously Treated Solid Tumors (CASTLE-11) (NCT06032845) | Fudan University | 2023-09-13 |
| Study of ADI-PEG 20 Versus Placebo in Subjects With NASH (NCT05842512) | Polaris Group | 2023-09-13 |
| Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322) (NCT05882734) | EMD Serono Research & Development Institute, Inc. | 2023-09-13 |
| Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer (NCT06081686) | Sinotau Pharmaceutical Group | 2023-09-13 |
| Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC) (NCT05377905) | Falo, Louis, MD | 2023-09-13 |
| A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain (NCT05838742) | GlaxoSmithKline | 2023-09-13 |
| "Receptor Radionuclide Therapy With 177Lu-DOTATOC (NCT06045260) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2023-09-13 |
| Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea (NCT06033352) | Insel Gruppe AG, University Hospital Bern | 2023-09-12 |
| A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA) (NCT06018428) | Q32 Bio Inc. | 2023-09-12 |
| Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds (NCT05800834) | Instituto Nacional de Cancer, Brazil | 2023-09-12 |
| Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H) (NCT06461793) | Samsung Medical Center | 2023-09-12 |
| A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC. (NCT06064812) | Forward Pharmaceuticals Co., Ltd. | 2023-09-12 |
| A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG (NCT06774222) | Henan Cancer Hospital | 2023-09-12 |
| Fellow-eye Study (FE) of LX101 in Subjects With Inherited Retinal Dystrophy (NCT06212297) | Innostellar Biotherapeutics Co.,Ltd | 2023-09-12 |
| Azeliragon in MGMT Unmethylated Glioblastoma (NCT05986851) | Cantex Pharmaceuticals | 2023-09-12 |
| Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries (NCT05849857) | Oslo University Hospital | 2023-09-11 |
| A Study to Evaluate the Safety and Efficacy of WS016 in Patients With Hyperkalemia. (NCT06277128) | Waterstone Pharmaceutical (Wuhan) Co., LTD. | 2023-09-11 |
| Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (NCT06028828) | University of California, Irvine | 2023-09-11 |
| Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder (NCT05886582) | Virginia Commonwealth University | 2023-09-11 |
| First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKI (NCT05920135) | Bridge Biotherapeutics, Inc. | 2023-09-11 |
| Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer (NCT05877430) | CJ Bioscience, Inc. | 2023-09-11 |
| Empagliflozin in Patients With Cirrhosis and Ascites (NCT05726032) | Yale University | 2023-09-11 |
| Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD (NCT06707753) | Beijing Anlong Biopharmaceutical Co., Ltd. | 2023-09-11 |
| A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia (NCT06118866) | Hope Medicine (Nanjing) Co., Ltd | 2023-09-11 |
| Early Parkinson's Disease Monotherapy With CVN424 (NCT06006247) | Cerevance Beta, Inc. | 2023-09-11 |
| A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants (NCT06083623) | Zhuhai Trinomab Pharmaceutical Co., Ltd. | 2023-09-11 |
| A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTI (NCT05826990) | Orchid Pharma Europe GmbH | 2023-09-11 |
| A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients (NCT05941793) | Oneness Biotech Co., Ltd. | 2023-09-11 |
| Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease (NCT05931575) | Technical University of Munich | 2023-09-11 |
| Metronidazole as Preoperative Therapy in CRC / FusoMetro-001 (NCT05748145) | Oncology Institute of Southern Switzerland | 2023-09-11 |
| NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy (NCT06024031) | Peking University People's Hospital | 2023-09-10 |
| Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma (NCT05622136) | Instituto do Cancer do Estado de São Paulo | 2023-09-10 |
| A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer (NCT06074484) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-09-10 |
| CURATE.AI Optimized Modulation for Multiple Myeloma (NCT03759093) | National University Hospital, Singapore | 2023-09-10 |
| Dead Mesenchymal Stem Cells for Radiation Lung Injury (NCT06021067) | Sichuan University | 2023-09-10 |
| Short-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALL (NCT06111625) | Sichuan University | 2023-09-10 |
| Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy (NCT06065722) | Simon Williamson Clinic | 2023-09-09 |
| Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer (NCT05860465) | Shanghai Pharmaceuticals Holding Co., Ltd | 2023-09-08 |
| A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma (NCT05664243) | In8bio Inc. | 2023-09-08 |
| NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration (NCT05984927) | Elisigen, Inc. | 2023-09-08 |
| Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine (NCT05846230) | Boehringer Ingelheim | 2023-09-08 |
| Study of INV-202 in Patients With Obesity and Metabolic Syndrome (NCT05891834) | Inversago Pharma Inc. | 2023-09-08 |
| Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis (NCT05532943) | Ever Supreme Bio Technology Co., Ltd. | 2023-09-08 |
| A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology (NCT05977998) | M.D. Anderson Cancer Center | 2023-09-08 |
| Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD (NCT04984226) | University of California, Davis | 2023-09-08 |
| RC108 Combine With Furmonertinib With/Without Toripalimab in Patients With EGFR-mutated NSCLC (NCT05821933) | RemeGen Co., Ltd. | 2023-09-07 |
| Evaluation of the Efficacy of CANNABIDIOL on the Pruritus in Children With Hereditary Epidermolysis Bullosa (NCT05651607) | Assistance Publique - Hôpitaux de Paris | 2023-09-07 |
| Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer (NCT06305832) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2023-09-07 |
| Rescue of Nephrons With ALE.F02 (RENAL-F02) (NCT06047171) | Alentis Therapeutics AG | 2023-09-07 |
| A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis. (NCT06028490) | Zheng Liu ENT | 2023-09-07 |
| APX005M in Patients With Recurrent Ovarian Cancer (NCT05201001) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2023-09-07 |
| Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis with Translocation (11;14) (NCT05996406) | Peking Union Medical College Hospital | 2023-09-07 |
| A Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004) (NCT05558696) | Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) | 2023-09-07 |
| CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors (NCT06006390) | Chongqing Precision Biotech Co., Ltd | 2023-09-07 |
| Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma (NCT05864742) | Peter MacCallum Cancer Centre, Australia | 2023-09-07 |
| A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. (NCT05975060) | Novavax | 2023-09-07 |
| OH2 Injection in Combination With BS006 Injection for Advanced Solid Tumors (NCT07382531) | Binhui Biopharmaceutical Co., Ltd. | 2023-09-07 |
| Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma (NCT06056336) | Guo Xufeng | 2023-09-07 |
| Senolytics to Improve Osteoporosis Therapy (NCT06018467) | Odense University Hospital | 2023-09-06 |
| D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients (NCT05734560) | Darell Bigner | 2023-09-06 |
| TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL (NCT06014073) | Chinese PLA General Hospital | 2023-09-06 |
| Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells (NCT06059690) | Jonsson Comprehensive Cancer Center | 2023-09-06 |
| The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function (NCT05972564) | Vanderbilt University Medical Center | 2023-09-06 |
| Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer (NCT06059547) | CatalYm GmbH | 2023-09-06 |
| Neurexan - a Clinical Trial in Short-Term Insomnia Patients (NCT06278077) | Biologische Heilmittel Heel GmbH | 2023-09-06 |
| Study of ART0380 in Patients With Biologically Selected Solid Tumors (NCT05798611) | Artios Pharma Ltd | 2023-09-06 |
| A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) (NCT05934513) | Genfleet Therapeutics (Shanghai) Inc. | 2023-09-06 |
| Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy (NCT05514340) | Pharmazz, Inc. | 2023-09-06 |
| Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome (NCT05926505) | Hellenic Institute for the Study of Sepsis | 2023-09-06 |
| A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes (NCT06033261) | ModernaTX, Inc. | 2023-09-06 |
| A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis (NCT06012812) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2023-09-06 |
| Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor (NCT05905887) | Asan Medical Center | 2023-09-06 |
| A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease (NCT06092034) | Rocket Pharmaceuticals Inc. | 2023-09-05 |
| Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy (NCT05833711) | Immunoforge Co. Ltd. | 2023-09-05 |
| Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study (NCT06033833) | Sanofi | 2023-09-05 |
| A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatment of Nasolabial Folds (NCT06018987) | AbbVie | 2023-09-05 |
| Overcoming Primary Resistance to Immunotherapy in Metastatic Melanoma (NCT05304546) | Dr. Ronnie Shapira | 2023-09-05 |
| Promoting Repigmentation After Epidermal Cell Suspension Grafting and preVENTing the Loss of Melanocytes Using Topical Ruxolitinib for Vitiligo in Resistant Areas (NCT05872477) | Centre Hospitalier Universitaire de Nice | 2023-09-05 |
| A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors (NCT06008366) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2023-09-05 |
| Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure (NCT06340048) | HELP Therapeutics Co., Ltd. | 2023-09-05 |
| Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis (NCT05979779) | Rivus Pharmaceuticals, Inc. | 2023-09-05 |
| Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma (NCT05635734) | Cantex Pharmaceuticals | 2023-09-05 |
| Directed Topical Drug Delivery for Treatment for PASC Hyposmia (NCT05970731) | Duke University | 2023-09-05 |
| A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) (NCT05652686) | Phanes Therapeutics | 2023-09-05 |
| Frameless Stereotactic Radiosurgery for Intact Brain Metastases (NCT02747303) | University of Chicago | 2023-09-05 |
| A Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & Smoker (NCT06156527) | National Cancer Center, Korea | 2023-09-05 |
| The Impact of Probiotics on Skin Hydration in Youth with Mild Acne (NCT05755256) | Lallemand Health Solutions | 2023-09-04 |
| Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy (NCT05848765) | University of Birmingham | 2023-09-04 |
| A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer or Other Solid Tumors (NCT05949619) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-09-04 |
| First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis) (NCT05832827) | National Cancer Center, Japan | 2023-09-04 |
| Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (NCT05891483) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2023-09-04 |